Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aloxi for CINV prevention in multiple myeloma stem cell transplant
NCT00306735Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Eisai Co., Ltd.. Started Mar 2006; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00306735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306735.